176 related articles for article (PubMed ID: 27339431)
1. The Past, Current Studies and Future of Organometallic 99mTc(CO)3 Labeled Peptides and Proteins.
Piramoon M; Hosseinimehr SJ
Curr Pharm Des; 2016; 22(31):4854-4867. PubMed ID: 27339431
[TBL] [Abstract][Full Text] [Related]
2. Mono-, bi-, or tridentate ligands? The labeling of peptides with 99mTc-carbonyls.
Alberto R; Pak JK; van Staveren D; Mundwiler S; Benny P
Biopolymers; 2004; 76(4):324-33. PubMed ID: 15386267
[TBL] [Abstract][Full Text] [Related]
3. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD
Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386
[TBL] [Abstract][Full Text] [Related]
6. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biodistribution and quantitative structure-activity relationship studies of new 99mTc labeled pseudo-peptide complexes.
Zhang H; Dai M; Qi C; Li B; Guo X
Appl Radiat Isot; 2004 May; 60(5):643-51. PubMed ID: 15082041
[TBL] [Abstract][Full Text] [Related]
8. "Click-to-chelate": in vitro and in vivo comparison of a 99mTc(CO)3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue.
Mindt TL; Müller C; Melis M; de Jong M; Schibli R
Bioconjug Chem; 2008 Aug; 19(8):1689-95. PubMed ID: 18646835
[TBL] [Abstract][Full Text] [Related]
9. Experiments on a new phosphine-peptide chelator for labelling of peptides with Tc-99m.
Santimaria M; Blok D; Feitsma RI; Mazzi U; Pauwels EK
Nucl Med Biol; 1999 Apr; 26(3):251-8. PubMed ID: 10363795
[TBL] [Abstract][Full Text] [Related]
10. New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.
Banerjee SR; Maresca KP; Francesconi L; Valliant J; Babich JW; Zubieta J
Nucl Med Biol; 2005 Jan; 32(1):1-20. PubMed ID: 15691657
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeling of fab and f(ab')2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand.
Misri R; Saatchi K; Häfeli UO
Nucl Med Commun; 2011 Apr; 32(4):324-9. PubMed ID: 21285909
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Broekema M; van Eerd JJ; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC; Harris TD
J Med Chem; 2005 Oct; 48(20):6442-53. PubMed ID: 16190770
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Co-Ligands on Improving Tumor Targeting of
Torabizadeh SA; Hosseinimehr SJ
Mini Rev Med Chem; 2017; 17(2):86-94. PubMed ID: 27515713
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in 99mTc radiopharmaceuticals.
Arano Y
Ann Nucl Med; 2002 Apr; 16(2):79-93. PubMed ID: 12043913
[TBL] [Abstract][Full Text] [Related]
15. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
16. Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.
Tournier N; André P; Blondeel S; Rizzo-Padoin N; du Moulinet d'Hardemarre A; Declèves X; Scherrmann JM; Cisternino S
J Pharm Sci; 2009 Dec; 98(12):4650-60. PubMed ID: 19492342
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
19. Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid.
Liu G; Dou S; He J; Vanderheyden JL; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2004; 15(6):1441-6. PubMed ID: 15546213
[TBL] [Abstract][Full Text] [Related]
20. Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.
Bullok KE; Dyszlewski M; Prior JL; Pica CM; Sharma V; Piwnica-Worms D
Bioconjug Chem; 2002; 13(6):1226-37. PubMed ID: 12440857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
